Revisiting the UK’s strategy for delaying the second dose of the Pfizer covid-19 vaccine
25 Jan, 2021 | 01:32h | UTC
Commentary on Twitter
These new data suggest that the UK govt should reconsider the decision to delay the second dose of the Pfizer/BioNTech vaccine. If they are determined to continue with the delayed second dose, then a robust randomized evaluation is urgently required https://t.co/4xrBFwZWkN
— The BMJ (@bmj_latest) January 24, 2021